KSQ Therapeutics' Series C Round

KSQ Therapeutics raised a round of funding on September 28, 2018.

KSQ Therapeutics aims to advance drugs via its proprietary CRISPRomics, which rules out inferior options from the outset, thereby focusing R&D investment on candidates with the greatest potential impa…

Articles about KSQ Therapeutics' Series C Round: